NCT06880614Completed
Effect of Acute Protein Supplementation in Diabetic Patients
Effect of House Cricket Preload on Glycemic Response in Type 2 Diabetes Patients
Source: ClinicalTrials.gov · Last updated 9 Dec 2025
Brief summary (registry, in English)
The goal of this trial is to test the effect of house cricket (Acheta domesticus) preload on glycemic response in diabetic patients. The main question\[s\] it aims to answer are: whether house cricket powder could lower blood glucose spike and stimulate higher insulin response. Participants will consume either house cricket powder, whey protein isolate or placebo which will be mixed with a chicken-flavored soup. Participants fingers will be pricked for up to 2 hours. Researcher will compare house cricket powder with placebo to see if the glycemic response is better in house cricket supplemented group. Researcher will compare house cricket powder with whey protein isolate to see if both supplement induce comparable glycemic response.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 14 Mar 2025
- Start date
- 1 Jun 2025
- Primary completion date
- 1 Dec 2025
- Lead sponsor
- University of Malaya
- Diseases
- Type 2 diabetes
- NCT number
- NCT06880614
What you commit to
- Study type: Interventional
- Participants enrolled: 20
- From 1 Jun 2025 to the primary completion date, 1 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Consume other type of anti-diabetic drugs
- Not consuming any anti-diabetic drugs
Other illness
- Presenting any food allergy
Lab values
- Recent surgery or infections that may affect oral glucose tolerance test
- Consume other drugs that may affect oral glucose tolerance test
- Pre-diabetes (HbA1c 5.7 - 6.4%)
Who the study is looking for
- Suffering from type 2 diabetes mellitus (HbA1c \> 6.5%)
- Consume metformin for at least 6 months
Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Queen Elizabeth Hospital Kota Kinabalu Coordinator of this site? Confirm its status | Kota Kinabalu | Malaysia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.